文献速递临床试验与 GCP

基于电影配音的语言治疗用于卒中后失语症(DULCINEA):随机交叉先导试验的研究方案

DUbbing Language-therapy CINEma-based in Aphasia post-Stroke (DULCINEA): study protocol for a randomized crossover pilot trial.
PubMed 文献 · Trials · 2022-01-06

该研究方案旨在开发并验证一种整合配音技术的新疗法,以改善卒中后失语症患者的功能性交流。研究分为三个工作包:开发基于配音的语言电影疗法、开展纳入54例卒中后非流利性失语症患者的随机交叉介入先导试验、以及教育和结果传播。主要结局为沟通活动日志问卷和波士顿失语症诊断检查的评分变化。

要点

  • 开发基于电影配音的语言疗法,通过在线调查筛选功能相关词汇。
  • 开展随机交叉先导试验,纳入54例卒中后非流利性失语症患者。
  • 主要结局为CAL问卷和BDAE评分,由对患者临床特征设盲的心理学家评估。

核心结论

  • 该先导临床试验将探索基于配音技术和计算机技术的新治疗工具在改善卒中后失语症患者功能性交流方面的疗效,采用标准化测验评估。

研究设计与样本

  • 研究项目分为三个工作包(WP)。
  • WP1:开发基于配音的语言电影疗法,由两名研究助理(一名言语治疗师和一名配音演员)选择片段,在渐进性言语难度中静音特定单词/句子,并指导患者跨会话进行配音;待配音的单词将由通过在线调查确定的失语症患者及亲属代表样本认定为具有功能意义。
  • WP2:一项随机、交叉、介入先导研究,纳入54例卒中后非流利性失语症患者;患者将接受个体化治疗,每次40分钟,每周两次,持续8周。
  • WP3:教育活动和结果传播,包括提高公众对失语症认识的教育活动,并与西班牙患者协会Afasia Activa合作传播结果。

主要发现

  • 主要结局为由对患者临床特征设盲的心理学家实施的沟通活动日志(CAL)问卷和波士顿失语症诊断检查(BDAE)评分在治疗前后的显著差异。
  • 次要结局包括一般健康问卷(GHQ)-12、卒中失语症生活质量量表(SAQOL-39)、西部失语症成套测验修订版(WAB-R)和卒中失语症抑郁问卷(SADQ10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Communication is one of the most important predictors of social reintegration after stroke. Approximately 15-42% of stroke survivors experience post-stroke aphasia. Helping people recover from aphasia is one of the research priorities after a stroke. Our aim is to develop and validate a new therapy integrating dubbing techniques to improve functional communication. METHODS: The research project is structured as three work packages (WP). WP1: development of the dubbed language cinema-based therapy: Two research assistants (a speech therapist and a dubbing actor) will select the clips, mute specific words/sentences in progressive speech difficulty, and guide patients to dub them across sessions. Words to be dubbed will be those considered to be functionally meaningful by a representative sample of aphasic patients and relatives through an online survey. WP2: a randomized, crossover, interventional pilot study with the inclusion of 54 patients with post-stroke non-fluent aphasia. Patients will be treated individually in 40-min sessions twice per week for 8 weeks. Primary outcomes will be significant pre/post differences in scores in the Communicative Activity Log (CAL) questionnaire and Boston Diagnostic Aphasia Examination (BDAE) administered by a psychologist blinded to the patients' clinical characteristics. SECONDARY OUTCOMES: General Health Questionnaire (GHQ)-12, Stroke Aphasia Quality of Life Scale (SAQOL-39), Western Aphasia Battery Revised (WAB-R), and the Stroke Aphasic Depression Questionnaire (SADQ10). WP3: educational activities and dissemination of results. WP3 includes educational activities to improve public knowledge of aphasia and dissemination of the results, with the participation of the Spanish patients' association Afasia Activa. DISCUSSION: This pilot clinical trial will explore the efficacy of a new therapeutic tool based on dubbing techniques and computer technology to improve functional communication of patients suffering from post-stroke aphasia with the use of standardized test assessment. TRIAL REGISTRATION: ClinicalTrials.gov NCT04289493 . Registered on 28 February 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fuentes B, de la Fuente-Gómez L, Sempere-Iborra C, et al. DUbbing Language-therapy CINEma-based in Aphasia post-Stroke (DULCINEA): study protocol for a randomized crossover pilot trial. Trials. 2022. PMID: 34991688. doi:10.1186/s13063-021-05956-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。